Skip to main content
    N

    Nexalin Technology Inc. (NXL)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $1.56
    +0.08 (+5.41%)

    Market Cap: $1.83M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Nexalin Technology Inc. (NXL) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Nexalin Technology are Nuwellis (NUWE), Beyond Air (XAIR) and enVVeno Medical (NVNO). By market cap, Nexalin Technology ranks 13th of the 13 companies on this page; Neuroone Medical Technologies (NMTC) is the largest at $6.78M.

    Peer Comparison

    NXL's ROIC of -609.2% is below the peer median of -130.3%, and its revenue growth of -82.8% is below the median of 17.7%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Nexalin Technology (NXL)$1.83MN/A4.4x0.0%-609.2%-82.8%0.00%
    Nuwellis Inc (NUWE)$2.65MN/AN/A-125.6%N/A14.1%0.00%
    Beyond Air Inc (XAIR)$3.55MN/A0.5x0.0%-113.5%0.5%0.00%
    enVVeno Medical Corp (NVNO)$4.29MN/AN/A0.0%N/A0.0%0.00%
    GlucoTrack Inc (GCTK)$2.43MN/AN/A0.0%-6319.2%0.0%0.00%
    Vivos Therapeutics Inc (VVOS)$3.29MN/A0.1x-121.8%-237.8%34.9%0.00%
    Neuroone Medical Technologies Corp (NMTC)$6.78MN/A0.7x-59.7%-147.0%16.3%0.00%
    Icecure Medical (ICCM)$3.39MN/A0.6x0.0%N/A72.8%0.00%
    Tenon Medical Inc (TNON)$3.79MN/A0.3x-257.9%N/A126.8%0.00%
    Co-Diagnostics, Inc. Common Stock (CODX)$2.72MN/A1.6x0.0%N/A94.6%0.00%
    Intelligent Bio Solutions Inc. (INBS)$5.84MN/A1.0x-269.3%N/A25.2%0.00%
    WORK Medical Technology Group LTD Ordinary Shares (WOK)$5.36MN/AN/A-41.9%-17.8%19.1%0.00%
    Trinity Biotech plc (TRIB)$4.96MN/AN/A-85.4%-14.3%-5.5%0.00%
    Peer median$3.67MN/A0.6x-50.8%-130.3%17.7%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Nexalin Technology, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Medical Devices.

    CompanyAboutPeers
    Nuwellis Inc (NUWE)
    Nuwellis, Inc., a medical device company, focuses on the development, manufacture and marketing of medical devices used in ultrafiltration therapy.
    NUWE competitors
    Beyond Air Inc (XAIR)
    Beyond Air, Inc., a clinical-stage biopharmaceutical and medical device company, develops nitric oxide (NO) generators and delivery systems.
    XAIR competitors
    enVVeno Medical Corp (NVNO)
    enVVeno Medical Corp (NVNO) is a pioneering medical device firm focused on revolutionizing vascular access solutions for dialysis patients with its proprietary...
    NVNO competitors
    GlucoTrack Inc (GCTK)
    GlucoTrack, Inc., a medical device company, designs, develops and markets noninvasive glucose monitoring devices for people with diabetes and prediabetes...
    GCTK competitors
    Vivos Therapeutics Inc (VVOS)
    Vivos Therapeutics, Inc., a medical technology company, is dedicated to developing and commercializing treatment alternatives for patients with sleep-disordered...
    VVOS competitors
    Neuroone Medical Technologies Corp (NMTC)
    NeuroOne Medical Technologies Corporation is a medical technology company. The company is headquartered in Eden Prairie, Minnesota.
    NMTC competitors
    Icecure Medical (ICCM)
    IceCure Medical Ltd develops and markets minimally invasive cryoablation therapies for the women's health and oncology markets.
    ICCM competitors
    Tenon Medical Inc (TNON)
    Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery and outcomes.
    TNON competitors
    Co-Diagnostics, Inc. Common Stock (CODX)
    Co-Diagnostics, Inc., a molecular diagnostic company, develops, manufactures, and sells reagents used for diagnostic tests that function by detecting and /...
    CODX competitors
    Intelligent Bio Solutions Inc. (INBS)
    Intelligent Bio Solutions Inc. (INBS) is a pioneering biotechnology company focused on delivering cutting-edge diagnostic solutions and biomarker-driven...
    INBS competitors
    WORK Medical Technology Group LTD Ordinary Shares (WOK)
    WORK Medical Technology Group Ltd is a pioneering player in the medical technology sector, dedicated to the advancement of healthcare through the research...
    Trinity Biotech plc (TRIB)
    Trinity Biotech plc acquires, develops, manufactures and markets medical diagnostic products for the clinical laboratory and point of care (POC) segments...
    TRIB competitors

    Frequently Asked Questions About NXL

    Who are Nexalin Technology's main competitors?

    The companies most similar to Nexalin Technology include Nuwellis (NUWE), Beyond Air (XAIR), enVVeno Medical (NVNO), GlucoTrack (GCTK) and Vivos Therapeutics (VVOS), listed from the closest match.

    Who is Nexalin Technology's biggest competitor?

    Neuroone Medical Technologies (NMTC) is the largest of the similar companies at $6.78M; Nuwellis (NUWE) is the closest match by business profile, size, sector and industry.

    How does NXL stock compare with its competitors?

    NXL's P/S is 4.4x against a peer median of 0.6x; its net margin is 0.0% against a peer median of -50.8%.

    Which of Nexalin Technology's competitors pays a higher dividend?

    Nexalin Technology pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Nexalin Technology bigger than its competitors?

    No. Nexalin Technology is 13th by market cap among the 13 companies on this page; the largest is Neuroone Medical Technologies (NMTC) at $6.78M.